Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age13-20
SponsorMassachusetts General Hospital

About this trial

The investigators will be evaluating bone marrow composition via magnetic resonance imaging in newly diagnosed adolescents with Crohn disease (CD) compared to healthy, matched controls. The investigators will also be assessing their bone mineral density via other imaging modalities, including dual-energy X-ray absorptiometry and peripheral quantitative computed tomography. This longitudinal project will focus on abnormalities in bone marrow composition, and specifically whether adolescents with newly diagnosed CD exhibit increased bone marrow fat, its association with bone mineral density (BMD) and the underlying pathophysiology, including bone turnover markers and immune cellular/molecular parameters.

Eligibility criteria

Qualifiers

Crohn's Disease diagnosed within the past 3 months, or a healthy, matched control

Disqualifiers

Participants with chronic disease known to affect skeletal metabolism

Participants on certain medications within the prior 3 months that are known to affect skeletal metabolism

Participants who are pregnant

Participants who have a history of: claustrophobia, internal body metal that is not compatible with MRI machine, or a known abnormality on or adjacent to the left knee

Trial design

Treatments tested in this trial

  • Coronal T1 weighted spin echo images
  • Spin-lattice relaxation (T1)
  • Magnetic resonance spectroscopy
  • Blood Draw

Treatment groups

92 Participants
are divided into 2 treatment groups

Sponsors and collaborators